Skip to Content
Shahab Akhter, MD

Contact Dr. Akhter


(608) 263-6551

H4/340A CSC
MADISON, WI 53792-0001

Shahab Akhter, MD

Chairman, Division of Cardiothoracic Surgery


  • MD, University of Chicago-Pritzker School of Medicine, Chicago, Illinois, 1993
  • General Surgery Residency, Duke University Medical Center, Durham, North Carolina, 2000
  • Cardiothoracic Surgery Residency, University of Michigan Medical Center, Ann Arbor, MI, 2002

Clinical Specialties

Dr. Akhter is certified by the American Board of Surgery and the American Board of Thoracic Surgery. He specializes in complex and high-risk cardiac surgery in adults. His particular areas of expertise include mitral and tricuspid valve repair, ventricular assist devices and heart transplantation, minimally invasive surgery for the treatment of atrial fibrillation, and re-operative cardiac surgery. Dr. Akhter also performs coronary artery bypass grafting, minimally invasive valve surgery, and transcatheter valve replacement.

Dr. Akhter provides a wide range of services including Angioplasty, Aortic Valve-Sparing Surgery, Aortic Valve-Sparing Surgery, Atrial Septal Defect (ASD) Repair, Atrial Septal Defect (ASD) Repair, Cardiac Resynchronization Therapy (CRT), Cardioversion, Carotid and Peripheral Blood Vessel Revascularization, Carotid Artery Stent, Carotid Surgery and Intervention, Cryoablation, Destination Therapy for End-Stage Heart Failure, Endoscopic Surveillance, Heart Bypass (Coronary Artery Bypass Graft Surgery - CABG), In Situ Vein Bypass for Limb Salvage, Limb Salvage, Maze Procedure (Minimally Invasive), Mitral Valve Repair, Pacemakers, Photodynamic Therapy, (show all).

Research Interests

Dr. Akhter’s clinical research focuses on optimizing outcomes in mechanical circulatory support for advanced heart failure and developing novel approaches for minimally invasive arrhythmia surgery. His laboratory research program investigates molecular mechanisms involved in the development of heart failure with the goal of discovering novel therapeutic strategies to prevent this disease process.

Active Clinical Trials
  • Rate Control Versus Rhythm Control For Postoperative Atrial Fibrillation
    Principal Investigator(s): Shahab Akhter, MD
    Status: Active, not recruiting
    [ NCT02132767]
    More Information
  • Safety & Efficacy of Intramyocardial Injection of Mesenchymal Precursor Cells on Myocardial Function in LVAD Recipients
    Principal Investigator(s): Shahab Akhter, MD
    Status: Recruiting
    [ NCT02362646]
    More Information
  • Thoratec Corporation MOMENTUM 3, Multi-center Study of MagLev Technology in Patients Undergoing MCS Therapy With HeartMate 3™ IDE Clinical Study Protocol
    Principal Investigator(s): Shahab Akhter, MD
    Status: Recruiting
    [ NCT02224755]
    More Information

Recent Publications
  • G protein-coupled receptor kinase-2 is a novel regulator of collagen synthesis in adult human cardiac fibroblasts.
    D'Souza KM, Malhotra R, Philip JL, Staron ML, Theccanat T, Jeevanandam V, Akhter SA
    J. Biol. Chem. 2015 Oct 23; 290(43):25849.
    [PubMed ID: 26500293, PMC ID: 4646240]
    More Information
  • Regulation of mitochondrial oxidative stress by β-arrestins in cardiac fibroblasts.
    Philip JL, Razzaque MA, Han M, Li J, Theccanat T, Xu X, Akhter SA
    Dis Model Mech 2015 Oct 8.
    [PubMed ID: 26449263]
    More Information
  • Invited Commentary.
    Akhter SA
    Ann. Thorac. Surg. 2015 Oct; 100(4):1297.
    [PubMed ID: 26434431]
    More Information
  • A novel approach to prevent post-operative ileus after continuous-flow left ventricular assist device implantation: A retrospective cohort study.
    Badami A, Fehrenbach Prell EA, Murray MA, Johnson MR, Akhter SA, Lozonschi L, Osaki S, Lushaj E, Kohmoto T
    Int J Surg 2015 Aug; 20():135-9.
    [PubMed ID: 26118604]
    More Information
  • Hospital Readmissions After Continuous-Flow Left Ventricular Assist Device Implantation: Incidence, Causes, and Cost Analysis.
    Akhter SA, Badami A, Murray M, Kohmoto T, Lozonschi L, Osaki S, Lushaj EB
    Ann. Thorac. Surg. 2015 Sep; 100(3):884-9.
    [PubMed ID: 26095106]
    More Information
  • Impact of age on outcomes following continuous-flow left ventricular assist device implantation.
    Lushaj EB, Badami A, Osaki S, Murray M, Leverson G, Lozonschi L, Akhter S, Kohmoto T
    Interact Cardiovasc Thorac Surg 2015 Jun; 20(6):743-8.
    [PubMed ID: 25770085]
    More Information
  • Reduction in driveline infection rates: Results from the HeartMate II Multicenter Driveline Silicone Skin Interface (SSI) Registry.
    Dean D, Kallel F, Ewald GA, Tatooles A, Sheridan BC, Brewer RJ, Caldeira C, Farrar DJ, Akhter SA, SSI Registry Investigators
    J. Heart Lung Transplant. 2015 Jun; 34(6):781-9.
    [PubMed ID: 25735901]
    More Information
  • Modified HeartMate II driveline externalization technique significantly decreases incidence of infection and improves long-term survival.
    Singh A, Russo MJ, Valeroso TB, Anderson AS, Rich JD, Jeevanandam V, Akhter SA
    ASAIO J. 2014 Nov-Dec; 60(6):613-6.
    [PubMed ID: 25072552]
    More Information
  • High-molecular-weight polyethylene glycol inhibits myocardial ischemia-reperfusion injury in vivo.
    Xu X, Philip JL, Razzaque MA, Lloyd JW, Muller CM, Akhter SA
    J. Thorac. Cardiovasc. Surg. 2015 Feb; 149(2):588-93.
    [PubMed ID: 25455467, PMC ID: 4459731]
    More Information
  • Connexin40 abnormalities and atrial fibrillation in the human heart.
    Gemel J, Levy AE, Simon AR, Bennett KB, Ai X, Akhter S, Beyer EC
    J. Mol. Cell. Cardiol. 2014 Nov; 76():159-68.
    [PubMed ID: 25200600, PMC ID: 4250516]
    More Information Copyright © 2015 The Board of Regents of the University of Wisconsin System